Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $35.0M | $26.9M | $12.8M | $6.5M | $457,661 | $215,409 | $415,162 | $536,396 | $555,355 |
| Gross profit | $19.1M | $12.0M | $6.2M | $1.0M | $42,277 | −$36,550 | $297,608 | $527,756 | $546,715 |
| Research & development | $0 | $0 | $0 | $1,800 | $0 | — | $0 | $17,752 | $91,131 |
| Operating expenses | $13.1M | $12.7M | $4.7M | $2.0M | $1.8M | $362,160 | $493,310 | $606,701 | $787,651 |
| Operating income | $6.1M | −$635,439 | $1.6M | −$990,850 | −$1.7M | −$398,710 | −$195,702 | −$78,945 | −$240,936 |
| EBITDAderived | — | — | — | — | — | −$146,751 | −$78,148 | −$70,305 | −$232,296 |
| Net income | $5.8M | $247,544 | $1.6M | −$1.1M | −$1.7M | −$458,490 | −$255,690 | −$141,088 | −$394,556 |
| Basic EPSper diluted share | $0.01 | $0.00 | $0.00 | $0.01 | -$0.02 | -$0.01 | $0.00 | $0.00 | -$0.01 |
| Diluted EPSper diluted share | $0.01 | $0.00 | $0.00 | -$0.01 | -$0.02 | -$0.01 | $0.00 | $0.00 | -$0.01 |